BCAP31 and steatosis: Loss of BAP31 impaired hepatic metabolic homeostasis by suppressing PPARα signaling, reducing fatty acid oxidation, and disrupting glycogen synthesis, leading to excessive lipid accumulation and exacerbated steatosis.